Skip to main content

Cipla gets USFDA nod for generic acid reflux drug

Cipla gets USFDA nod for generic acid reflux drug Cipla is the first company to file for the 10mg strength, it added. The product is a generic version of AstraZeneca Pharmaceutical#39;s Nexium. It is indicated for the treatment of gastroesophageal reflux disease, risk reduction of NSAID-associated gastric ulcer, among others, Cipla said.

from Moneycontrol Business News https://ift.tt/2UBKnkF

Comments

Popular posts from this blog

List of tax defaulters to be published from tomorrow: Kiran Bedi

Bedi had said the government would publish the names of defaulters in newspapers and also announce them on FM radio channels. from Moneycontrol Business News https://ift.tt/2yU0Uch

German cabinet to hold secret session on Huawei#39;s role in 5G network: Report

Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology for spying, which the company denies. from Moneycontrol Business News http://bit.ly/2TyXzFb

List of tax defaulters to be published from Friday: Kiran Bedi

Bedi had said the government would publish the names of defaulters in newspapers and also announce them on FM radio channels. from Moneycontrol Business News https://ift.tt/2yToJRc